Special Problems in the Management of Advanced Breast Cancer
Breast Cancer is a systemic disease at the time a clinical diagnosis is established in the majority of patients. This concept is the basis of current efforts to improve survival with adjuvant systemic therapy. Similarly, patients with recurrent breast cancer can be assumed to have widely disseminated disease when the recurrence is first diagnosed. Many of these patients will develop problems related to individual sites of metastases. In this chapter, we examine some of the problems encountered in the management of patients with specific sites of metastatic involvement.
KeywordsOsteoporosis Radioactive Isotope Dexamethasone Prostaglandin Methotrexate
Unable to display preview. Download preview PDF.
- 6.Green N, Keen W, Levis R, Schleiter W, Bonorris J, Berne CJ (1977) Lymphangitic carcinomatosis of the lung: pathologic diagnostic and treatment considerations. Int J Radiat Oncol Bio Phys 2:149–153Google Scholar
- 9.Hendrickson FR (1977) The optimal schedule for palliative radiotherapy for metastatic brain cancer. Int J Radiat Oncol Bio Phys 2:165–168Google Scholar
- 14.Bullock JD et al. (1980) Ophthalmic manifestations of metastatic breast cancer. Ophthalmol 87:961–973Google Scholar